Literature DB >> 486848

Dichotic perception: evidence for right hemisphere dysfunction in affective psychosis.

A Yozawitz, G Bruder, S Sutton, L Sharpe, B Gurland, J Fleiss, L Costa.   

Abstract

The association between lateralized hemispheric dysfunction and psychiatric diagnosis was investigated with a measure of summation of dichotic clicks and with a dichotic competing message task. Ear asymmetries of affective psychotic patients were similar to those of right temporal lesioned controls and differed from those of schizophrenic patients and normal controls. In contrast, schizophrenic patients did not display abnormal auditory perceptual asymmetries.

Entities:  

Mesh:

Year:  1979        PMID: 486848     DOI: 10.1192/bjp.135.3.224

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

1.  Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.

Authors:  B Saletu; J Grünberger; P Anderer; L Linzmayer; H V Semlitsch; G Magni
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

Review 2.  The neuropsychology of depression and its implications for cognitive therapy.

Authors:  W D Crews; D W Harrison
Journal:  Neuropsychol Rev       Date:  1995-06       Impact factor: 7.444

3.  Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; P Anderer; L Linzmayer; G Zyhlarz
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  Resting state alpha oscillatory activity is a valid and reliable marker of schizotypy.

Authors:  Jelena Trajkovic; Francesco Di Gregorio; Francesca Ferri; Chiara Marzi; Stefano Diciotti; Vincenzo Romei
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

5.  Stimulus-dependent effects on right ear advantage in schizophrenia.

Authors:  Jason Smucny; Korey Wylie; Jason Tregellas
Journal:  Neuropsychiatr Dis Treat       Date:  2012-09-21       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.